304 related articles for article (PubMed ID: 22872171)
21. Angiotensin IV Receptors Mediate the Cognitive and Cerebrovascular Benefits of Losartan in a Mouse Model of Alzheimer's Disease.
Royea J; Zhang L; Tong XK; Hamel E
J Neurosci; 2017 May; 37(22):5562-5573. PubMed ID: 28476949
[TBL] [Abstract][Full Text] [Related]
22. NADPH-oxidase-derived reactive oxygen species mediate the cerebrovascular dysfunction induced by the amyloid beta peptide.
Park L; Anrather J; Zhou P; Frys K; Pitstick R; Younkin S; Carlson GA; Iadecola C
J Neurosci; 2005 Feb; 25(7):1769-77. PubMed ID: 15716413
[TBL] [Abstract][Full Text] [Related]
23. High-Fat-Diet Intake Enhances Cerebral Amyloid Angiopathy and Cognitive Impairment in a Mouse Model of Alzheimer's Disease, Independently of Metabolic Disorders.
Lin B; Hasegawa Y; Takane K; Koibuchi N; Cao C; Kim-Mitsuyama S
J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 27412896
[TBL] [Abstract][Full Text] [Related]
24. Cerebrovascular disease in the elderly: lipoprotein metabolism and cognitive decline.
Panza F; Solfrizzi V; Colacicco AM; D'Introno A; Capurso C; Palasciano R; Todarello O; Capurso S; Pellicani V; Capurso A
Aging Clin Exp Res; 2006 Apr; 18(2):144-8. PubMed ID: 16702784
[TBL] [Abstract][Full Text] [Related]
25. Role of vascular hypoperfusion-induced oxidative stress and mitochondria failure in the pathogenesis of Azheimer disease.
Aliev G; Smith MA; Obrenovich ME; de la Torre JC; Perry G
Neurotox Res; 2003; 5(7):491-504. PubMed ID: 14715433
[TBL] [Abstract][Full Text] [Related]
26. Brain Vasculature and Cognition.
Fouda AY; Fagan SC; Ergul A
Arterioscler Thromb Vasc Biol; 2019 Apr; 39(4):593-602. PubMed ID: 30816798
[TBL] [Abstract][Full Text] [Related]
27. Severe chronic cerebral hypoperfusion induces microglial dysfunction leading to memory loss in APPswe/PS1 mice.
Bordeleau M; ElAli A; Rivest S
Oncotarget; 2016 Mar; 7(11):11864-80. PubMed ID: 26918610
[TBL] [Abstract][Full Text] [Related]
28. Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology.
Isopi E; Granzotto A; Corona C; Bomba M; Ciavardelli D; Curcio M; Canzoniero LM; Navarra R; Lattanzio R; Piantelli M; Sensi SL
Neurobiol Dis; 2015 Sep; 81():214-24. PubMed ID: 25434488
[TBL] [Abstract][Full Text] [Related]
29. Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease.
Reed BR; Mungas DM; Kramer JH; Ellis W; Vinters HV; Zarow C; Jagust WJ; Chui HC
Brain; 2007 Mar; 130(Pt 3):731-9. PubMed ID: 17267522
[TBL] [Abstract][Full Text] [Related]
30. Apoptosis signal-regulating kinase 1 is a novel target molecule for cognitive impairment induced by chronic cerebral hypoperfusion.
Toyama K; Koibuchi N; Uekawa K; Hasegawa Y; Kataoka K; Katayama T; Sueta D; Ma MJ; Nakagawa T; Yasuda O; Tomimoto H; Ichijo H; Ogawa H; Kim-Mitsuyama S
Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):616-25. PubMed ID: 24371084
[TBL] [Abstract][Full Text] [Related]
31. Alzheimer's disease is a vasocognopathy: a new term to describe its nature.
de la Torre JC
Neurol Res; 2004 Jul; 26(5):517-24. PubMed ID: 15265269
[TBL] [Abstract][Full Text] [Related]
32. Vascular cognitive impairment.
O'Brien JT; Erkinjuntti T; Reisberg B; Roman G; Sawada T; Pantoni L; Bowler JV; Ballard C; DeCarli C; Gorelick PB; Rockwood K; Burns A; Gauthier S; DeKosky ST
Lancet Neurol; 2003 Feb; 2(2):89-98. PubMed ID: 12849265
[TBL] [Abstract][Full Text] [Related]
33. Verapamil attenuates scopolamine induced cognitive deficits by averting oxidative stress and mitochondrial injury - A potential therapeutic agent for Alzheimer's Disease.
Ponne S; Kumar CR; Boopathy R
Metab Brain Dis; 2020 Mar; 35(3):503-515. PubMed ID: 31691145
[TBL] [Abstract][Full Text] [Related]
34. Cognitive impairment in humanized APP×PS1 mice is linked to Aβ(1-42) and NOX activation.
Bruce-Keller AJ; Gupta S; Knight AG; Beckett TL; McMullen JM; Davis PR; Murphy MP; Van Eldik LJ; St Clair D; Keller JN
Neurobiol Dis; 2011 Dec; 44(3):317-26. PubMed ID: 21798347
[TBL] [Abstract][Full Text] [Related]
35. Reactive oxygen species in the cerebral circulation: physiological roles and therapeutic implications for hypertension and stroke.
Paravicini TM; Drummond GR; Sobey CG
Drugs; 2004; 64(19):2143-57. PubMed ID: 15456332
[TBL] [Abstract][Full Text] [Related]
36. Hippocampal nitric oxide upregulation precedes memory loss and A beta 1-40 accumulation after chronic brain hypoperfusion in rats.
de la Torre JC; Pappas BA; Prevot V; Emmerling MR; Mantione K; Fortin T; Watson MD; Stefano GB
Neurol Res; 2003 Sep; 25(6):635-41. PubMed ID: 14503018
[TBL] [Abstract][Full Text] [Related]
37. Oxidative Stress in the Pathogenesis of Alzheimer's Disease and Cerebrovascular Disease with Therapeutic Implications.
Jurcau A; Simion A
CNS Neurol Disord Drug Targets; 2020; 19(2):94-108. PubMed ID: 32124703
[TBL] [Abstract][Full Text] [Related]
38. [Investigation of the effect of vinpocetine on cerebral blood flow and cognitive functions].
Valikovics A
Ideggyogy Sz; 2007 Jul; 60(7-8):301-10. PubMed ID: 17713111
[TBL] [Abstract][Full Text] [Related]
39. The role of oxidative stress and NADPH oxidase in cerebrovascular disease.
Chrissobolis S; Faraci FM
Trends Mol Med; 2008 Nov; 14(11):495-502. PubMed ID: 18929509
[TBL] [Abstract][Full Text] [Related]
40. Cerebrovascular disease and cognitive dysfunction.
Lanzino G; Lanzino DJ; Wang D
Neurol Res; 2002 Jun; 24(4):331-6. PubMed ID: 12069278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
